Figure 4From: Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone Assessment of adverse events, medical costs (1€ = 150JPY) and the cumulative dose of prednisolone (PSL) in two groups of patients with active ulcerative colitis (UC) who received GMA or PSL as a treatment intervention. This figure shows GMA has favourable safety over PSL, while the treatment cost is in favour of PSL.Back to article page